Spotlight on Neuromuscular Diseases: Pathomechanisms and New Therapeutic Targets
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (20 November 2024) | Viewed by 17373
Special Issue Editors
Interests: basic research; neuromuscular disorders; myositis; immune regulations; immune cells; histology; gene analyses
Special Issues, Collections and Topics in MDPI journals
Interests: clinical neurology; neuroimmunology; neuroinflammation; myasthenia gravis
2. Department of Neuropediatrics and Neuromuscular Centre for Children and Adolescents, Center for Translational Neuro- and Behavioral Sciences, University Duisburg-Essen, 45147 Essen, Germany
Interests: neurodegenerative and neuromuscular disorders
Interests: basic research; neuromuscular disorders; autoimmunity; myositis; myopathies; myasthenia gravis; immune cell activation; immune cell function; immune cell migration; immune cell maturation
Special Issues, Collections and Topics in MDPI journals
Interests: translational research; myositis; connective tissue diseases; autoimmunity; immune cell function; immune cell differentiation; biomarkers; histology; new therapeutic approaches
Special Issue Information
Dear Colleagues,
Neuromuscular diseases (NMD) encompass cellular malfunctions affecting the peripheral nervous system, the neuromuscular junctions or the skeletal muscles or even a combination of such. Although individual entities often qualify as rare diseases, the entire group of NMDs affects a significant number of people of all age groups and further research is urgently needed. Atrophy, degeneration, and inflammation are typical phenomena that can e.g., result from external stimuli, infections, autoimmunity or genetic causes. While ongoing research and our ever-growing knowledge is paving the way for new treatment options, many entities still lack specific treatment options. Here, pre-clinical research is an important prerequisite for the identification and definition of new starting points for therapeutic intervention concepts as well as for patient stratification.
Along this line, one of the current challenges remains in understanding the underlying disease-specific pathomechanisms and moving toward patient-oriented, individualized treatment. To highlight this need, we provide the current special issue of Cells, which aims to address all forms of neuromuscular diseases. The focus lies on implementation of new developments, studies from basic research to patient stratification, including biomarker discovery and the definition of novel therapeutic targets to clinical applications.
We look forward to your exciting contributions.
Dr. Corinna Preusse
Dr. Sarah Hoffmann
Dr. Andreas Roos
Prof. Dr. Tobias Ruck
Guest Editors
Marie-Therese Holzer
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuromuscular disorders
- myositis
- myasthenia gravis
- genetic mutations
- muscle inflammation
- de-/regeneration
- immune cell infiltration
- new therapy options
- targeted therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.